Prior antiviral treatment and mortality among patients with hepatitis C virus-related hepatocellular carcinoma: A national cohort study

BACKGROUND: The current antiviral treatments available for hepatitis C virus (HCV) infection decrease the risk of hepatocellular carcinoma (HCC). Hence, patients with HCV infection who have not received antiviral treatment and have developed HCC may be those who missed timely antiviral treatment for...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinn, Dong Hyun, Kang, Danbee, Hong, Yun Soo, Koh, Kwang Cheol, Guallar, Eliseo, Cho, Juhee, Gwak, Geum-Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330890/
https://www.ncbi.nlm.nih.gov/pubmed/34343200
http://dx.doi.org/10.1371/journal.pone.0255624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330890/
https://www.ncbi.nlm.nih.gov/pubmed/34343200
http://dx.doi.org/10.1371/journal.pone.0255624

Ejemplares similares